Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Boudi1959on Jul 18, 2021 6:35pm
272 Views
Post# 33567305

Read this guys

Read this guys

THRM obtained a CE, isn't it? Using white label or something like that!

Applying for a temporary exemption

Currently rapid tests are formally classified as medical devices and may only be used under the medical responsibility of a doctor. They cannot simply be marketed as self-tests. However, starting this week, manufacturers and distributors of rapid antigen tests will be able to apply for an exemption to market their product as a self-test. Manufacturers have to meet certain requirements to obtain such an exemption. For instance, the product must already bear a CE marking for professional use as a rapid antigen test and must have been validated for use as a self-test. Exemptions can be granted within a week. Please refer to the ‘Procedure to obtain exemption for rapid antigen test for use as self-test’ for the complete list of requirements and further information. Granted exemptions will initially be valid until 31 December 2021.

The ministry has asked a group of experts to come up with a practical solution by the end of this month to clear the way for supervised self-testing using antigen tests for businesses and educational institutions.

<< Previous
Bullboard Posts
Next >>